Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03247322 · ClinicalTrials.gov registry record · NA
mHealth Medication Safety Intervention
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
NCT03247322 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 136 participants.
The verdict
NCT03247322, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
Study Summary
TRANSAFE Rx is a 12-month, parallel two-arm, 1:1 randomized controlled clinical trial, involving 136 participants (68 in each arm) measuring the clinical and economic effectiveness of a pharmacist-led intervention, which utilizes an innovative mHealth application to improve medication safety and health outcomes, as compared to usual post-transplant care. The primary goal of the TRANSAFE Rx study is to demonstrate significant reductions in med safety issues leading to reduced healthcare resource utilization in kidney transplantation through a pharmacist-led, mHealth-enabled, intervention. This study will provide detailed and novel information on the incidence, etiologies and outcomes of med errors and adverse drug events in this high-risk population; while also demonstrating the effectiveness of this intervention on reducing the incidence and impact of med safety issues in kidney transplantation.
Interventions
- OTHER Pharmacist-led medication therapy using mHealth application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2017-10-11 |
| Est. Completion | 2020-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03247322
The ClinicalTrials.gov registry entry for NCT03247322 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pharmacist-led medication therapy using mHealth application is the first listed.
NCT03247322 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03247322 about?
NCT03247322 is a clinical study titled "mHealth Medication Safety Intervention". TRANSAFE Rx is a 12-month, parallel two-arm, 1:1 randomized controlled clinical trial, involving 136 participants (68 in each arm) measuring the clinical and economic effectiveness of a pharmacist-led intervention, which utilizes an innovative mHealth application to improve medication safety and hea...
What is the current status of trial NCT03247322?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2017-10-11. Estimated completion is 2020-05-30.
What interventions are being tested in trial NCT03247322?
The interventions under investigation include: Pharmacist-led medication therapy using mHealth application (OTHER).
Who is sponsoring clinical trial NCT03247322?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.